FDA Inspection 1255916 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on October 30, 2024 in Clayton, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 30, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Clayton, NC (United States)